{
  "docId": "019dd923-5ca1-7489-b639-45501f4b359b",
  "docSlug": "158df8627a0b9aca",
  "documentTitle": "Opioid Conflicts Majority Staff Report",
  "authorId": "McKinsey",
  "authorName": "U.S. House Committee on Oversight and Reform",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 10,
  "pageCount": 53,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "appendix_disclosure",
  "function": "other",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "This appears to be a page from a formal report or legal document, likely an appendix or disclosure section.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/10",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-10",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Of the 37 FDA contracts for which McKinsey provided staffing information to the Committee, Mr. Smith was staffed on 28 of them.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-cdec-74db-b499-899bdb579a78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.764,
        "x": 0.118,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "At the same time that Mr. Smith was working for FDA, internal McKinsey documents show he was also a leader of McKinsey’s consulting work for Purdue. From 2009 to 2017, Mr.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11c66f9f-0051-46e8-8f06-e9edf3433b92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.764,
        "x": 0.118,
        "y": 0.163
      },
      "kind": "paragraph",
      "text": "Although Mr. Singh was not formally identified as a consultant to Purdue, he appears to have been held out in communications with Purdue as a potential source of expertise.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b6c43a8-192c-4272-a5c1-4a24afc8fed3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.085,
        "w": 0.764,
        "x": 0.118,
        "y": 0.255
      },
      "kind": "paragraph",
      "text": "Internally, Mr. Singh appears to have served as an informal advisor to McKinsey teams working on Purdue matters. In 2009 and 2010, Purdue engaged McKinsey to assist in preparing a regulatory submission to FDA concerning the safety and utility of Purdue’s “BuTrans” opioid dispensing patch.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f4022ea-1389-4e5e-a453-11e011340e48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.115,
        "w": 0.764,
        "x": 0.118,
        "y": 0.515
      },
      "kind": "paragraph",
      "text": "McKinsey Partner Jeff Smith is a senior consultant who worked extensively for both FDA and opioid manufacturers. FDA contracts and proposals describe Mr. Smith as a “core member of McKinsey’s client service team to FDA” since 2007 who has served “on multiple engagements with CDER, the Center for Biologics Evaluation and Research (CBER), the Office of the Commissioner, and the Office of Regulatory Affairs.” Of the 37 FDA contracts for which McKinsey provided staffing information to the Committee, Mr. Smith is staffed on 28 of them.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d377382-b9a4-4146-a3e5-367f52c9c279",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.764,
        "x": 0.118,
        "y": 0.116
      },
      "kind": "paragraph",
      "text": "be in meetings and workshops at FDA the whole day. I come up for air at 6 pm and happy [sic] to take a look at the proposal.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc01c0b5-bbc7-4cbd-bd76-b46f5ea26856",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.764,
        "x": 0.118,
        "y": 0.392
      },
      "kind": "paragraph",
      "text": "A 2014 presentation to Purdue’s new CEO Mark Timney stated that McKinsey would “bring to bear” Mr. Singh’s expertise in “regulatory agencies,” in its work for Purdue, while an email from 2017 referred to “ancient work product” that Mr. Singh and another McKinsey consultant completed for Purdue.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0bffd3d-734a-4223-ac25-7dc438dca346",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.764,
        "x": 0.118,
        "y": 0.74
      },
      "kind": "source-note",
      "text": "17-23 citations listed at the bottom of the page.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed23e7be-a803-4c92-9ebe-bff6cffe9c2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.12,
        "x": 0.118,
        "y": 0.48
      },
      "kind": "title",
      "text": "Jeff Smith",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0533b622-c25d-4c05-952f-c8046004186c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 6,
      "beatId": "ca9c3ab4-903c-4ff0-b53d-42335d2ce596",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The document presents extensive evidence of McKinsey's conflicts of interest, including consultant overlaps and contract details.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 53,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033",
      "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}